Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006
Increased nitrosative stress in COPD airways: validation and measurement in exhaled breath condensate Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Parameters of oxidative stress in exhaled breath condensate are more pronounced in females then in males with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 728s Year: 2005
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010
Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable? Source: Eur Respir J 2004; 23: 183-184 Year: 2004
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Is exhaled breath temperature a useful marker of pulmonary inflammation? Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008
Oxidative stress in the exhaled breath condensate of patients with acute pulmonary infections Source: Eur Respir J 2005; 26: Suppl. 49, 405s Year: 2005
MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Dynamics of oxidative stress parameters in exhaled breath condensate at controller treatment of bronchial asthma in patients with cold airway hyperpesponsiveness Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Oxidative stress in expired breath condensate of patients with COPD: relationships with airway inflammation, and disease severity Source: Eur Respir J 2002; 20: Suppl. 38, 284s Year: 2002
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition? Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004